Hochschulschrift
Structural and functional characterisation of human cytomegalovirus encoded glycoprotein US6
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
xi, 127 Seiten
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Johann Wolfgang Goethe-Universität in Frankfurt am Main, Dissertation, 2022
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:04 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2021
Other Objects (12)
Immunomodulation by the human cytomegalovirus glycoprotein pUL11
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Functional and structural dissection of the human cytomegalovirus encoded immunoevasin US11 reveals co-adaptation to HLA-A
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Role of envelope glycoprotein complexes in cell-associated spread of human cytomegalovirus
Identification of a Human Cytomegalovirus-encoded Jak1 antagonist using a novel screening strategy
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Ein Glycoprotein des murinen Cytomegalovirus hemmt den Transport von MHC-Klasse-I-Komplexen
Immunomodulation by the human cytomegalovirus glycoprotein pUL11
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Functional and structural dissection of the human cytomegalovirus encoded immunoevasin US11 reveals co-adaptation to HLA-A
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Role of envelope glycoprotein complexes in cell-associated spread of human cytomegalovirus
Identification of a Human Cytomegalovirus-encoded Jak1 antagonist using a novel screening strategy
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Ein Glycoprotein des murinen Cytomegalovirus hemmt den Transport von MHC-Klasse-I-Komplexen
Immunomodulation by the human cytomegalovirus glycoprotein pUL11
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Functional and structural dissection of the human cytomegalovirus encoded immunoevasin US11 reveals co-adaptation to HLA-A
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Role of envelope glycoprotein complexes in cell-associated spread of human cytomegalovirus
Identification of a Human Cytomegalovirus-encoded Jak1 antagonist using a novel screening strategy
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus